Whither thyrotoxicosis?
For 30 years the thyrotoxic patient has been subjected to a plurality of treatments by surgery, radio-iodine and long term anti-thyroid drugs. These therapies have been accepted as complementary to the needs of the individual patient, without regard for long term results or the economic situation as it affects both patient and hospital services. In the context of surgical treatment which is now available, it is suggested that the advantages of operation over other therapies presage a reversion to surgery as the treatment of choice.
D000469:Alkaline Phosphatase / Q000097:blood; D002118:Calcium / Q000097:blood; D006470:Hemorrhage / Q000150:complications; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D006996:Hypocalcemia / Q000209:etiology; D007037:Hypothyroidism / Q000209:etiology / Q000473:pathology; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D061224:Laryngeal Nerve Injuries; D009929:Organ Size; D011183:Postoperative Complications; D011433:Propranolol / Q000627:therapeutic use; D061226:Recurrent Laryngeal Nerve Injuries; D013564:Sympathetic Nervous System / Q000293:injuries; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000473:pathology; D013965:Thyroidectomy
D007457:Iodine Radioisotopes; D011433:Propranolol; D000469:Alkaline Phosphatase; D002118:Calcium